This list is an analysis based on recent market events. It's not an investment recommendation.
Alzai Health Corp. develops a disease risk screening platform, enabling disease prevention and early disease diagnosis to improve patient outcomes. The company was founded by Hayim Raclaw, Roy Kait and Ofri Kait on November 15, 2024 and is headquartered in Toronto, Canada.
FAQs
What is Alzai Health stock price today?▼
The current price of H2F.F is €0.08 EUR — it has decreased by -0.26% in the past 24 hours. Watch Alzai Health stock price performance more closely on the chart.
What is Alzai Health stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Alzai Health stocks are traded under the ticker H2F.F.
What is Alzai Health market cap?▼
Today Alzai Health has the market capitalization of 5.05M
What is Alzai Health revenue for the last year?▼
Alzai Health revenue for the last year amounts to 16,732.09 EUR.
What is Alzai Health net income for the last year?▼
H2F.F net income for the last year is -2.29M EUR.
How many employees does Alzai Health have?▼
As of November 1, 2026, the company has 5 employees.
In which sector is Alzai Health located?▼
Alzai Health operates in the Other sector.
When did Alzai Health complete a stock split?▼
Alzai Health has not had any recent stock splits.
Where is Alzai Health headquartered?▼
Alzai Health is headquartered in Toronto, Canada.